With the advancement in technology
and discovery of new products in the field of medical sciences, vaccines have
gained crucial position in the pharmaceutical industry. Vaccines are
considered as the most effective health intervention ever developed, saving
innumerable lives. The vaccine market is growing at a steady pace, mainly
because of the various existing and emerging diseases which can only be
prevented with the help of vaccines. Scientists are continuously engaged in
the research and development of effective vaccines to eradicate all major life
threatening diseases. There are various organizations namely the Global
Alliance for Vaccines and Immunizations (GAVI), World Health Organization
(WHO), the World Bank, the United Nations Children's Fund (UNICEF) and Bill
and Melinda Gates foundation, which supply vaccines at subsidize rate or even
free of cost.
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/global-influenza-flu-vaccine-market-trends-and-opportunities-2014-19
Influenza vaccine constitutes a
significant segment of overall vaccine market. The large public attention
associated with Influenza A (H1N1, swine flu) pandemic in 2009, growing health
awareness in emerging countries has played a significant role in determining
the dynamics of the global influenza market.
Scope of the Report
The report titled “Global Influenza
(Flu) Vaccine Market: Trends and Opportunities (2014-2019)” provides an
insight into the market dynamics and various trends and opportunities
associated with the global Influenza vaccine market. It covers the global
market size and growth dynamics of the influenza vaccine market in past five
years. The report further forecasts the market size for the coming five years
along with factors that could influence the market dynamics in the projected
period. The report also captures the market share based on major players in
the market. Further, the report also analyzes the domestic Influenza vaccine
market of United States, Japan, Germany and United Kingdom. The report
concludes with a brief discussion of key factors trending in the global
influenza vaccine market and profiles major players like Sanofi, Abbott
Laboratories, Novartis, CSL and Glaxo Smith Kline.
Geographical Coverage
- Global
- United States
- Japan
- Germany
- United Kingdom
Company Coverage
- Sanofi
- Abbott Laboratories
- Novartis
- CSL
- Glaxo Smith Kline
Table of Content
1. Executive Summary
2. Global Influenza (Flu) Market:
An Introduction
3. Global Vaccine Market: An
Analysis
3.1. Global Vaccine Market: Sizing
& Growth (Actual & Forecast)
3.2. Global vaccine Market:
Segmentation
3.2.1. Human Vaccine Market: Sizing
& Growth (Actual & Forecast)
3.2.2. Veterinary Vaccine: Market
Sizing & Growth (Actual & Forecast)
4. Global Influenza Market: An
Analysis
4.1. Global Influenza Market:
Sizing & Growth (Actual & Forecast)
4.2. Global Influenza Vaccine
Market: Sizing & Growth (Actual & Forecast)
4.3. Global Influenza Vaccine
Market Share Analysis
4.3.1. Market Share: By Capacity
4.3.2. Market Share: By Revenue
4.4. Global Seasonal Flu Vaccine
Market Trend
5. Seasonal Influenza Vaccine
Market: Regional Analysis
5.1. United States Seasonal
Influenza Vaccine Market: Sizing & Growth (Actual & Growth)
5.2. Japan Seasonal Influenza
Vaccine Market: Sizing & Growth (Actual & Growth)
5.3. Germany Seasonal Influenza
Vaccine Market: Sizing & Growth (Actual & Growth)
5.4. United Kingdom Seasonal
Influenza Vaccine Market: Sizing & Growth (Actual & Growth)
6. Global Influenza Vaccine Market
Trend
7. Company Profiles
7.1. Sanofi
7.1.1 Business Description
7.1.2. Financial Highlights
7.1.3. Business Strategies
7.2. Abbott Laboratories
7.2.1. Business Description
7.2.2. Financial Highlights
7.2.3. Business Strategies
7.3. Novartis
7.3.1. Business Description
7.3.2. Financial Highlights
7.3.3. Business Strategies
7.4. CSL
7.4.1. Business Description
7.4.2. Financial Highlights
7.4.3. Business Strategies
7.5. Glaxo Smith Kline
7.5.1. Business Strategies
7.5.2. Financial Highlights
7.5.3. Business Strategies
Table 1: Number of Doses sold by
Novartis, 2013, (Million)
Figure 1: Global Vaccine Market
Size, 2008-2013, (US$ Billion)
Figure 2: Global Vaccine Market
Size Forecast, 2014-2019, (US$ Billion)
Figure 3: Global Human Vaccine
Market Size, 2008-2013, (US$ Billion)
Figure 4: Global Human Vaccine
Market Size Forecast, 2014-2019, (US$ Billion)
Figure 5: Global Veterinary Vaccine
Market Size, 2008-2013, (US$ Billion)
Figure 6: Global Veterinary Vaccine
Market Size Forecast, 2014-2019, (US$ Billion)
Figure 7: Global Influenza Market
Size, 2008-2013, (US$ Billion)
Figure 8: Global Influenza Market
Size Forecast, 2014-2019, (US$ Billion)
Figure 9: Global Influenza Vaccine
Market Size, 2008-2013, (US$ Billion)
Figure 10: Global Influenza Vaccine
Market Size Forecast, 2014-2019, (US$ Billion)
Figure 11: Global Influenza Vaccine
Capacity Market Share, By Major Players, 2012
Figure 12: Global Influenza Vaccine
Market Share, By Major Players
Figure 13: Global Seasonal Flu
Vaccine Market Size, By Region, 2008-2013 (US$ Million)
Figure 14: United States Seasonal
Influenza Vaccine Market Size, 2008-2013, (US$ Million)
Figure 15: United States Seasonal
Influenza Vaccine Market Size Forecast, 2014-2019, (US$ Million)
Figure 16: Japan Seasonal Influenza
Vaccine Market Size, 2008-2013, (US$ Million)
Figure 17: Japan Seasonal Influenza
Vaccine Market Size Forecast, 2014-2019, (US$ Million)
Figure 18: Germany Seasonal
Influenza Vaccine Market Size, 2008-2013, (US$ Million)Figure 19: Germany
Seasonal Influenza Vaccine Market Size Forecast, 2014-2019, (US$ Million)
Figure 20: United Kingdom Seasonal
Influenza Vaccine Market Size, 2008-2013, (US$ Million)
Figure 21: United Kingdom Seasonal
Influenza Vaccine Market Size Forecast, 2014-2019, (US$ Million)
Figure 22: Sanofi Vaccine Net
Sales, 2009-2013 (US$ Million)
Figure 23: Abbott Net Sales,
2011-2013 (US$ Billion)
Figure 24: Novartis Vaccine &
Diagnostics Net Sales, 2009-2013 (US$ Million)
Figure 25: Novartis Net Sales, By
Sector (FY’ 2013)
Figure 26: CSL Global Revenue,
FY’2009-FY’2013 (US$ Million)
Figure 27: CSL Limited Net Sales,
By Sector (First Half FY’ 2014)
Figure 28: GSK Flaurix/Flulaval
Turnover, 2010-2013 (US$ Million)
Figure 29: GSK Global Turnover, By
Segment, 2013
Figure 30: GSK Global Turnover, By
Region, 2013
|
Office: United States
|
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
No comments:
Post a Comment